<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36556030</PMID><DateRevised><Year>2022</Year><Month>12</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>24</Issue><PubDate><Year>2022</Year><Month>Dec</Month><Day>14</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Prevalence and Persistence of Symptoms in Adult COVID-19 Survivors 3 and 18 Months after Discharge from Hospital or Corona Hotels.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">7413</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm11247413</ELocationID><Abstract><AbstractText>COVID-19 is characterized by persistent symptoms beyond acute illness. In this prospective cohort study of patients with COVID-19, we sought to characterize the prevalence and persistence of symptoms up to 18 months after diagnosis. We followed 166 patients and assessed their symptoms during acute illness, and at 3 and 18 months after disease onset. The mean number of symptoms per patient during acute disease was 2.3 (SD:1.2), dropping to 1.8 (SD:1.1) at 3 months after recovery and to 0.6 (SD:0.9) at 18 months after recovery. However, this decrease was not unidirectional. Between acute illness and 3 months, the frequency of symptoms decreased for cough (64.5%&#x2192;24.7%), ageusia (21.7% to6%), anosmia (17.5%&#x2192;5.4%), and generalized pain (10.8% to 5.4%) but increased for dyspnea (53%&#x2192;57.2%) weakness (47%&#x2192;54.8%), and brain fog (3%&#x2192;8.4%). Between 3 and 18 months, the frequency of symptoms decreased for all symptoms but remained relatively high for dyspnea (15.8%), weakness (21.2%), and brain fog (7.3%). Symptoms may persist for at least 18 months after acute COVID-19 infection. During the medium- to long-term recovery period, the prevalence of some symptoms may decrease or remain stable, and the prevalence of others may increase before slowly decreasing thereafter. These data should be considered when planning post-acute care for these patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kalak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Medicine, Pulmonary Institute, Shaare Zedek Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 9112102, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jarjou'i</LastName><ForeName>Amir</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-8304-0117</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Pulmonary Institute, Shaare Zedek Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 9112102, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bohadana</LastName><ForeName>Abraham</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine, Pulmonary Institute, Shaare Zedek Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 9112102, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wild</LastName><ForeName>Pascal</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>PW Statistical Consulting, 54520 Laxou, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rokach</LastName><ForeName>Ariel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine, Pulmonary Institute, Shaare Zedek Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 9112102, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amiad</LastName><ForeName>Noa</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 9112102, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdelrahman</LastName><ForeName>Nader</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Medicine, Pulmonary Institute, Shaare Zedek Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 9112102, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arish</LastName><ForeName>Nissim</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Medicine, Pulmonary Institute, Shaare Zedek Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 9112102, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen-Shuali</LastName><ForeName>Chen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Medicine, Pulmonary Institute, Shaare Zedek Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 9112102, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Izbicki</LastName><ForeName>Gabriel</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-3455-5480</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Pulmonary Institute, Shaare Zedek Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 9112102, Israel.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 symptoms</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">persistent symptoms</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. Neither Mada&#x2019;it SZ nor Keren Louzon Fund had a role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>11</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>23</Day><Hour>1</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>24</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36556030</ArticleId><ArticleId IdType="pmc">PMC9784691</ArticleId><ArticleId IdType="doi">10.3390/jcm11247413</ArticleId><ArticleId IdType="pii">jcm11247413</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wiersinga W.J., Rhodes A., Cheng A.C., Peacock S.J., Prescott H.C. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA. 2020;324:782&#x2013;793. doi: 10.1001/jama.2020.12839.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12839</ArticleId><ArticleId IdType="pubmed">32648899</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., et al. Post-Acute COVID-19 Syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Fajnzylber J., Regan J., Coxen K., Corry H., Wong C., Rosenthal A., Worrall D., Giguel F., Piechocka-Trocha A., Atyeo C., et al. SARS-CoV-2 Viral Load Is Associated with Increased Disease Severity and Mortality. Nat. Commun. 2020;11:5493. doi: 10.1038/s41467-020-19057-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19057-5</ArticleId><ArticleId IdType="pmc">PMC7603483</ArticleId><ArticleId IdType="pubmed">33127906</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasserie T., Hittle M., Goodman S.N. Assessment of the Frequency and Variety of Persistent Symptoms among Patients with COVID-19. JAMA Netw. Open. 2021;4:e2111417. doi: 10.1001/jamanetworkopen.2021.11417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.11417</ArticleId><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D., Hu B., Hu C., Zhu F., Liu X., Zhang J., Wang B., Xiang H., Cheng Z., Xiong Y., et al. Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus&#x2013;Infected Pneumonia in Wuhan, China. JAMA. 2020;323:1061&#x2013;1069. doi: 10.1001/jama.2020.1585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.1585</ArticleId><ArticleId IdType="pmc">PMC7042881</ArticleId><ArticleId IdType="pubmed">32031570</ArticleId></ArticleIdList></Reference><Reference><Citation>The Writing Committee for the COMEBAC Study Group Four-Month Clinical Status of a Cohort of Patients after Hospitalization for COVID-19. JAMA. 2021;325:1525&#x2013;1534. doi: 10.1001/jama.2021.3331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.3331</ArticleId><ArticleId IdType="pmc">PMC7970386</ArticleId><ArticleId IdType="pubmed">33729425</ArticleId></ArticleIdList></Reference><Reference><Citation>Go&#xeb;rtz Y.M.J., Herck M.V., Delbressine J.M., Vaes A.W., Meys R., Machado F.V.C., Houben-Wilke S., Burtin C., Posthuma R., Franssen F.M.E., et al. Persistent Symptoms 3 Months after a SARS-CoV-2 Infection: The Post-COVID-19 Syndrome? ERJ Open Res. 2020;6:542&#x2013;2020. doi: 10.1183/23120541.00542-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00542-2020</ArticleId><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosn J., Piroth L., Epaulard O., Le Turnier P., Mentr&#xe9; F., Bachelet D., Laou&#xe9;nan C. Persistent COVID-19 Symptoms Are Highly Prevalent 6 Months after Hospitalization: Results from a Large Prospective Cohort. Clin. Microbiol. Infect. 2021;27:1041.e1. doi: 10.1016/j.cmi.2021.03.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.03.012</ArticleId><ArticleId IdType="pmc">PMC8107834</ArticleId><ArticleId IdType="pubmed">34125067</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., Kang L., Guo L., Liu M., Zhou X., et al. 6-Month Consequences of COVID-19 in Patients Discharged from Hospital: A Cohort Study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y., Shang Y., Song W., Li Q., Xie H., Xu Q., Jia J., Li L., Mao H., Zhou X., et al. Follow-up Study of the Pulmonary Function and Related Physiological Characteristics of COVID-19 Survivors Three Months after Recovery. EClinicalMedicine. 2020;25:100463. doi: 10.1016/j.eclinm.2020.100463.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100463</ArticleId><ArticleId IdType="pmc">PMC7361108</ArticleId><ArticleId IdType="pubmed">32838236</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel A., Jernigan D.B., Abdirizak F., Abedi G., Aggarwal S., Albina D., Allen E., Andersen L., Anderson J., Anderson M., et al. Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak&#x2014;United States, December 31, 2019&#x2013;February 4, 2020. MMWR. Morb. Mortal. Wkly. Rep. 2020;69:140&#x2013;146. doi: 10.15585/mmwr.mm6905e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6905e1</ArticleId><ArticleId IdType="pmc">PMC7004396</ArticleId><ArticleId IdType="pubmed">32027631</ArticleId></ArticleIdList></Reference><Reference><Citation>McHorney C.A., Ware J.E., Rachel Lu J.F., Sherbourne C.D. The MOS 36-Ltem Short-Form Health Survey (SF-36): III. Tests of Data Quality, Scaling Assumptions, and Reliability across Diverse Patient Groups. Med. Care. 1994;32:40&#x2013;66. doi: 10.1097/00005650-199401000-00004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005650-199401000-00004</ArticleId><ArticleId IdType="pubmed">8277801</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuty Kuswardhani R.A., Henrina J., Pranata R., Anthonius Lim M., Lawrensia S., Suastika K. Charlson Comorbidity Index and a Composite of Poor Outcomes in COVID-19 Patients: A Systematic Review and Meta-Analysis. Diabetes Metab. Syndr. Clin. Res. Rev. 2020;14:2103&#x2013;2109. doi: 10.1016/j.dsx.2020.10.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2020.10.022</ArticleId><ArticleId IdType="pmc">PMC7598371</ArticleId><ArticleId IdType="pubmed">33161221</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin S.R., Wong Y.-N., Uzzo R.G., Beck J.R., Egleston B.L. Why Summary Comorbidity Measures such as the Charlson Comorbidity Index and Elixhauser Score Work. Med. Care. 2015;53:e65&#x2013;e72. doi: 10.1097/MLR.0b013e318297429c.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MLR.0b013e318297429c</ArticleId><ArticleId IdType="pmc">PMC3818341</ArticleId><ArticleId IdType="pubmed">23703645</ArticleId></ArticleIdList></Reference><Reference><Citation>NIH  Clinical Spectrum.  [(accessed on 7 May 2022)]; Available online:  https://www.covid19treatmentguidelines.nih.gov/overview/clinical-spectrum/</Citation></Reference><Reference><Citation>Gebhard C., Regitz-Zagrosek V., Neuhauser H.K., Morgan R., Klein S.L. Impact of Sex and Gender on COVID-19 Outcomes in Europe. Biol. Sex Differ. 2020;11:29. doi: 10.1186/s13293-020-00304-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13293-020-00304-9</ArticleId><ArticleId IdType="pmc">PMC7247289</ArticleId><ArticleId IdType="pubmed">32450906</ArticleId></ArticleIdList></Reference><Reference><Citation>Shastri M.D., Shukla S.D., Chong W.C., KC R., Dua K., Patel R.P., Peterson G.M., O&#x2019;Toole R.F. Smoking and COVID-19: What We Know so Far. Respir. Med. 2021;176:106237. doi: 10.1016/j.rmed.2020.106237.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2020.106237</ArticleId><ArticleId IdType="pmc">PMC7674982</ArticleId><ArticleId IdType="pubmed">33246296</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Palacios-Ce&#xf1;a D., G&#xf3;mez-Mayordomo V., Florencio L.L., Cuadrado M.L., Plaza-Manzano G., Navarro-Santana M. Prevalence of Post-COVID-19 Symptoms in Hospitalized and Non-Hospitalized COVID-19 Survivors: A Systematic Review and Meta-Analysis. Eur. J. Intern. Med. 2021;92:55&#x2013;70. doi: 10.1016/j.ejim.2021.06.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2021.06.009</ArticleId><ArticleId IdType="pmc">PMC8206636</ArticleId><ArticleId IdType="pubmed">34167876</ArticleId></ArticleIdList></Reference><Reference><Citation>See&#xdf;le J., Waterboer T., Hippchen T., Simon J., Kirchner M., Lim A., M&#xfc;ller B., Merle U. Persistent Symptoms in Adult Patients One Year after COVID-19: A Prospective Cohort Study. Clin. Infect. Dis. 2021;74:1191&#x2013;1198. doi: 10.1093/cid/ciab611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab611</ArticleId><ArticleId IdType="pmc">PMC8394862</ArticleId><ArticleId IdType="pubmed">34223884</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., Graham M.S., Penfold R.S., Bowyer R.C., Pujol J.C., Klaser K., Antonelli M., Canas L.S., et al. Attributes and Predictors of Long COVID. Nat. Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho-Schneider C., Laurent E., Lemaignen A., Beaufils E., Bourbao-Tournois C., Laribi S., Flament T., Ferreira-Maldent N., Bruy&#xe8;re F., Stefic K., et al. Follow-up of Adults with Non-Critical COVID-19 Two Months after Symptoms&#x2019; Onset. Clin. Microbiol. Infect. 2020;27:258&#x2013;263. doi: 10.1016/j.cmi.2020.09.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.052</ArticleId><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H., Raza S., Nowell J., Young M., Edison P. Long Covid&#x2014;Mechanisms, Risk Factors, and Management. BMJ. 2021;374:n1648. doi: 10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin M., Schommers P., Stecher M., Dewald F., Gieselmann L., Gruell H., Horn C., Vanshylla K., Cristanziano V.D., Osebold L., et al. Post-COVID Syndrome in Non-Hospitalised Patients with COVID-19: A Longitudinal Prospective Cohort Study. Lancet Reg. Health-Eur. 2021;6:100122. doi: 10.1016/j.lanepe.2021.100122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100122</ArticleId><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C., Pellicer-Valero O.J., Navarro-Pardo E., Palacios-Ce&#xf1;a D., Florencio L.L., Guijarro C., Mart&#xed;n-Guerrero J.D. Symptoms Experienced at the Acute Phase of SARS-CoV-2 Infection as Risk Factor of Long-Term Post-COVID Symptoms: The LONG-COVID-EXP-CM Multicenter Study. Int. J. Infect. Dis. 2022;116:241&#x2013;244. doi: 10.1016/j.ijid.2022.01.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2022.01.007</ArticleId><ArticleId IdType="pmc">PMC8743274</ArticleId><ArticleId IdType="pubmed">35017102</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabatabaei S.M.H., Rajebi H., Moghaddas F., Ghasemiadl M., Talari H. Chest CT in COVID-19 Pneumonia: What Are the Findings in Mid-Term Follow-Up? Emerg. Radiol. 2020;27:711&#x2013;719. doi: 10.1007/s10140-020-01869-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10140-020-01869-z</ArticleId><ArticleId IdType="pmc">PMC7649573</ArticleId><ArticleId IdType="pubmed">33165674</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M., Manoharan L., Elkheir N., Cheng V., Dagens A., Hastie C., O&#x2019;Hara M., Suett J., Dahmash D., Bugaeva P., et al. Characterising Long COVID: A Living Systematic Review. BMJ Glob. Health. 2021;6:e005427. doi: 10.1136/bmjgh-2021-005427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H., Rostami M.R., Leopold P.L., Mezey J.G., O&#x2019;Beirne S.L., Strulovici-Barel Y., Crystal R.G. Expression of the SARS-CoV-2 ACE2 Receptor in the Human Airway Epithelium. Am. J. Respir. Crit. Care Med. 2020;202:219&#x2013;229. doi: 10.1164/rccm.202003-0541OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202003-0541OC</ArticleId><ArticleId IdType="pmc">PMC7365377</ArticleId><ArticleId IdType="pubmed">32432483</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai G., Boss&#xe9; Y., Xiao F., Kheradmand F., Amos C.I. Tobacco Smoking Increases the Lung Gene Expression of ACE2, the Receptor of SARS-CoV-2. Am. J. Respir. Crit. Care Med. 2020;201:1557&#x2013;1559. doi: 10.1164/rccm.202003-0693LE.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202003-0693LE</ArticleId><ArticleId IdType="pmc">PMC7301735</ArticleId><ArticleId IdType="pubmed">32329629</ArticleId></ArticleIdList></Reference><Reference><Citation>Dessie Z.G., Zewotir T. Mortality-Related Risk Factors of COVID-19: A Systematic Review and Meta-Analysis of 42 Studies and 423,117 Patients. BMC Infect. Dis. 2021;21:855. doi: 10.1186/s12879-021-06536-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-021-06536-3</ArticleId><ArticleId IdType="pmc">PMC8380115</ArticleId><ArticleId IdType="pubmed">34418980</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Zyl-Smit R.N., Richards G., Leone F.T. Tobacco Smoking and COVID-19 Infection. Lancet Respir. Med. 2020;8:664&#x2013;665. doi: 10.1016/S2213-2600(20)30239-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30239-3</ArticleId><ArticleId IdType="pmc">PMC7247798</ArticleId><ArticleId IdType="pubmed">32464099</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahamat-Saleh Y., Fiolet T., Rebeaud M.E., Mulot M., Guihur A., El Fatouhi D., Laouali N., Peiffer-Smadja N., Aune D., Severi G. Diabetes, Hypertension, Body Mass Index, Smoking and COVID-19-Related Mortality: A Systematic Review and Meta-Analysis of Observational Studies. BMJ Open. 2021;11:e052777. doi: 10.1136/bmjopen-2021-052777.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-052777</ArticleId><ArticleId IdType="pmc">PMC8557249</ArticleId><ArticleId IdType="pubmed">34697120</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Q., Meng M., Kumar R., Wu Y., Huang J., Lian N., Deng Y., Lin S. The Impact of COPD and Smoking History on the Severity of COVID-19: A Systemic Review and Meta-Analysis. J. Med. Virol. 2020;92:1915&#x2013;1921. doi: 10.1002/jmv.25889.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25889</ArticleId><ArticleId IdType="pmc">PMC7262275</ArticleId><ArticleId IdType="pubmed">32293753</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>